There is ample evidence that links sugar-sweetened beverage consumption to adverse effects on metabolic risk factors, such as dyslipidemia [35,41,42,58,59,60,61,62,63,64,65] and insulin resistance [35,41,42,58,61,65]. This evidence concerns the gene INS and metabolic syndrome.